GlassScriptPhysician profile
Sara D Herman
NPI 1689932261
$1,549.34
in general payments reported to CMS, 2019-2025
24 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $105 · 2021: $22.39 · 2023: $341 · 2024: $474 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.65 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.48 | 2019-2025 | |
| Janssen Biotech, INC. | $172.75 | 2023-2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $104.49 | 2023-2024 | Sotyktu |
| Genzyme Corporation | $99.11 | 2025 | |
| Pfizer INC. | $84.38 | 2019-2024 | |
| Lilly USA, LLC | $71.35 | 2019-2023 | Taltz, Olumiant |
| Fresenius Kabi USA, LLC | $57.38 | 2023-2024 | Idacio |
| Arcutis Biotherapeutics, INC. | $57.29 | 2023-2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.13 | 2023-2024 | Spevigo |
| Leo Pharma INC. | $42.38 | 2024-2025 | Adbry |
| Mayne Pharma Commercial LLC | $38.84 | 2019-2020 | |
| Epi Health, LLC | $37.35 | 2019-2020 | |
| Ucb, INC. | $35.33 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $30.89 | 2019 | |
| Sun Pharmaceutical Industries INC. | $29.67 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $29.27 | 2024 | Libtayo |
| Almirall LLC | $28.71 | 2019 | |
| Kyowa Kirin, INC. | $24.12 | 2024 | Poteligeo |
| Celgene Corporation | $20.09 | 2019 | |
| Dusa Pharmaceuticals, INC. | $19.80 | 2019 | |
| Galderma Laboratories, L.P. | $14.46 | 2019 | |
| Promius Pharma LLC | $14.27 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.25 | 2019 | |
| Strata Skin Sciences, INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.